Summary The ability of 1,9-dideoxyforskolin (DDF), 1-deoxyforskolin (DF) and forskolin to modulate cellular sensitivity to vinblastine (VBL) was examined in drug-sensitive parental KB-3-1 cells and a multidrugresistant subline, KB-GRC1, derived by transfection of mdrl. Fifty gM DF and forskolin enhanced the 1 h uptake of VBL by 8.0 ± 0.7 (s.d.) and 4.7 ± 2.5-fold, respectively, with 501lM DDF producing a 13.6 ± 1.9-fold increase. The greater effect of DDF relative to forskolin indicated that the effect was independent of activation of cAMP, and this was supported by a lack of effect of dibutyryl cAMP on the uptake. The effect of these agents on uptake were < 1. 
The concept that tumour cell sensitivity to anticancer drugs can be regulated by activation of signal transduction pathways has been established (Abraham et al., 1990; . The protein kinase A and C pathways have been reported to regulate sensitivity to drugs that participate in the MDR3 phenotype (Abraham et al., 1990; Fine et al., 1988; Hamada et al., 1987) . Wadler & Wiernik (1988) demonstrated that the diterpene, forskolin, a stimulator of adenylyl cyclase which catalyses formation of cAMP (Laurenza et al., 1989) , and its inactive analogue, DDF, partially reversed resistance to doxorubicin in murine sarcoma S180 cells. Experiments aimed at examining the effect of the diterpenes on doxorubin efflux showed no change in the rate of initial efflux, and inconsistent effects on terminal efflux in either drug-resistant or -sensitive cells. Thus, their data suggested involvement of both cAMP-dependent and -independent mechanisms for the reversal of resistance, but these mechanisms were not elucidated nor were they definitively linked with modulation of the mdrl gene product, PGP. Forskolin and DDF are known to inhibit the activity of the glucose transporter, and of cholinergic and gabaminergic ion channels, all of which share a membrane-spanning homology with PGP (Laurenza et al., 1989) . Furthermore, adenylyl cyclase and PGP are structurally similar (Krupinski et al., 1989) . These findings have stimulated further interest in studying forskolin and DDF as modulators of drug sensitivity. During the course of this study, Morris and coworkers (1991) reported that forskolin and DDF selectively enhanced the cytotoxicity of doxorubicin in VBL-resistant SKLVLB cell lines in vitro and correlated the enhanced toxicity with the ability of photoactive analogues of forskolin to interact directly with PGP.
We chose to examine the role of cAMP in modulating the uptake and efflux of another substrate that participates in the MDR phenotype, VBL, employing a well-defined MDR cell line (Juranka et al., 1989) , examining the effect of the diterpenes on the efflux pumping activity of PGP. The cell model chosen utilised an MDR variant, KB-GRC1, and its drug-sensitive parental cell line, KB-3-1. KB-GRC1 cells were derived from KB-3-1 cells by transfection of the mdrl gene (Choi et al., 1988) , and theoretically differ from KB-3-1 only by expression of PGP following the transfection (Choi et al., 1988) . KB-GRC1 cells are 67, 9.4, 4.5. and 1.5-fold cross-resistant to VBL, doxorubicin, colchicine and etoposide, respectively, (ibid., Shalinsky et al., 1990a) . This model should lack the confounding influence of other changes (Chabner & Fojo, 1989) Eastman (1983) .
[3H]-VBL (10-20Cimmol'1) in methanol was purchased under a special quality-control contract to ensure high purity from Moravek Biochemicals (Brea, CA), stored in the dark at -80'C and protected from light during experiments. The purity of [3H]-VBL was confirmed by HPLC analysis according to the method of Thimmaiah and Sethi (1985 (Choi et al., 1988) , and are classically multidrug resistant (ibid., Shalinsky et al., 1990a) .
Mouse L cell variants, KK, MM and NEO (Morse & Roninson, 1990) L cell variants were grown in the presence of 0.4 mg ml-' G-418 sulfate. Routine culture conditions have been previously described (Shalinsky et al., 1990a) .
Modulation of cellular pharmacology Six nM [3H]-VBL and DDF, DF or forskolin (501M or as noted) were added to subconfluent cultures in 60-mm dishes in 2 ml of culture medium equilibrated overnight in the CO2 incubator. Uptake was determined as previously described (Shalinsky et al., 1993) . Briefly, aliquots of a subsequently homogenised cellular suspension were used for determination of protein content and cell-associated radioactivity.
Efflux was determined after loading the cells with 6 nM
[3H]-VBL for 2 h until steady-state had been reached. Efflux was monitored from 30 s to 3 h as previously described (ibid.). The per cent of intracellular VBL that was proteinbound was also determined as previously described (ibid.).
Cytotoxicity assays Cytotoxicity was measured using a continuous exposure colony forming assay as previously described (Shalinsky et al., 1990a Median effect analysis of the nature of the interaction between DDF and VBL was performed as previously described (ibid.). This analysis yields the combination index, a measure of the extent of synergy, additivity or antagonism at various levels of cell kill (Chou & Talalay, 1984 Figure 3 shows the time course of the uptake under control conditions and in the presence of DDF, DF or forskolin. Several points are evident. First, the large decrease in uptake in the KB-GRC1 relative to the KB-3-1 cell line confirmed the over-expression of a wildtype PGP in the KB-GRCI cells. Second, the effects of the diterpenes were greater in the KB-GRCI cells with DDF, DF and forskolin enhancing VBL content at 1 h by 13.6 ± 1.9, 8.0 ± 0.7 and 4.7 ± 2.5-fold, respectively. In contrast, the same agents produced only a 1.4 ± 0.3, 1.3 ± 0.05 and 1.2 ± 0.04-fold increase in KB-3-1 cells, respectively. These data demonstrate that DDF was the most potent of these diterpenes and that PGP was a likely target for the modulation.
The effect of dibutyryl cAMP (Robison et al., 1968) on VBL uptake was examined to determine the effect of increasing cAMP content independent of any other effect that forskolin might have. Dibutyryl cAMP did not affect the I h uptake in either cell line at concentrations of 0.01-5.O M (data not shown). These concentrations have been reported to produce a maximal increase in protein kinase A activity in neoplastic cells in vitro, an increase that is sufficient to mediate cAMP-dependent transport of other cytotoxic drugs . Thus, an increase in cAMP content was likely not required for modulation of VBL uptake, consistent with the fact that the magnitude of DDF's effect was substantially larger than that of forskolin.
Modulation of influx We have previously described the presence of a rapidly-acting PGP efflux transporter in KB-GRC1 cells that functions to reduce VBL uptake even during the initial seconds of exposure (Shalinsky et al., 1990b; Shalinsky et al., 1993) . In a direct comparison between KB-GRC1 and KB-3-1 cells, the lowered apparent influx was associated only with the enhanced efflux in KB-GRCI, indicating that the PGP efflux activity manifested as both reduced influx and enhanced efflux. Thus, Figure 4 shows the apparent influx over the initial 120 s that is due to PGP efflux activity. The ability of PGP to reduce net accumulation was evident at times < 30 s, resulting in an approximate 2-fold decrease in the influx of VBL in KB-GRCI cells. In KB-GRCGI cells, the diterpene pattern of modulation was the same as in Figure 3 , and all three agents produced large increases in influx. However, there was a more pronounced effect of DDF and DF on [3H]-VBL influx in the KB-3-1 cells than was predicated from the magnitude of the effect of these agents at 1 h. The influx data were well fit by a straight line (r2> 0.94). Table I (Shalinsky et al., 1993) . dKK vs MM control: P-value <0.001. (Juranka et al., 1989) . These data confirmed that DDF was selective in its modulatory ability toward MDR drugs. Cytotoxic studies The ability of the diterpenes to selectively augment VBL uptake suggested that they would selectively enhance VBL cytotoxicity in KB-GRCI cells. As shown in Figure 8 , the sensitivity of the KB cell lines to DDF and forskolin was determined. Each cell line was more resistant to forskolin than to DDF. A non-toxic concentration of 20JM of each modulator was used for subsequent studies. Figure 9 illustrates the ability of DDF and forskolin to enhance the cytotoxicity of VBL. In these experiments, KB-GRCI cells were 27-fold resistant to VBL relative to KB-3-1 cells; the IC50 values were 18.9 ± 4.5 and 0.7 ± 0.3 nM, respectively. In KB-GRCI cells, DDF increased the sensitivity to VBL by 7-fold, whereas forskolin had a discernable 1.5-fold effect. In contrast in KB-3-1 cells, neither DDF nor forskolin affected the VBL dose response curve. Median effect analysis was used to determine the nature of the interaction between DDF and VBL in KB-GRCI cells. Median effect analysis yielded CT20, C150 and C180 values of 0.21 ± 0.05, 0.20 ± 0.05 and 0.18 ± 0.04, respectively (n = 2). CI values less than 1 indicate synergy, thus there was a highly synergistic interaction between DDF and VBL in the KB-GRCI cells. Drug Figure 7 Ability of 50 ;LM DDF to enhance the I h uptake of radiolabelled 6 nM VBL, 1 lLM doxorubicin (DOX), 10 nM methotrexate (MTX) or 51M DEP in KB cells. Control pmol drug accumulated mg-' cellular protein for each drug is shown in parentheses. Values are mean ± s.d. of 2-5 experiments.
Discussion
In this report, we demonstrate that the diterpene analogues, and notably DDF, selectively modulate VBL uptake, efflux and sensitivity in tumour cells over-expressing mdrl. These data demonstrate the feasibility of modulating sensitivity to a KB-GRC1 vinca alkaloid commonly used for the treatment of cancer. These data, when viewed in context with a previous report (Morris et al., 1991) establish inhibition of PGP-mediated efflux as a primary mechanism. Forskolin was chosen for investigation because it activates protein kinase A indirectly (Laurenza et al., 1989) and alteration of protein kinase A has been shown to alter drug sensitivity (Abraham et al., 1990 ) and phosphorylation of PGP (Meyers, 1989; Mellado & Horwitz, 1987) . Forskolin also interacts with membrane-spanning proteins, such as adenylyl cyclase, and glucose and ion transporters, known to be homologous to PGP (Morris et al., 1991; Krupinski et al., 1989) .
While PGP may be phosphorylated by protein kinase C and other kinases (Fine et al., 1988; Hamada et al., 1987; Staats et al., 1990) , the effect of PKC-activation is typically a decrease in the level of drug accumulated. We have confirmed that phorbol-treatment leads to decreased VBL uptake in KB-GRCI cells (Shalinsky and Howell, unpublished data) suggesting that PGP-mediated efflux was stimulated by the treatment. Thus, a similar role for cAMP can be excluded because forskolin enhanced, not decreased, VBL uptake. Further studies examining PKC were not pursued since the diterpenes appear to selectively alter PKA rather than PKC pathways (Robison et al., 1968; Laurenza et al., 1989) . However, the possibility that the diterpenes may inhibit PKC-mediated pathways to enhance VBL uptake can not be ruled out.
The approach was aimed instead at examining the involvement of cAMP based on the fact that forskolin directly activates adenylate cyclase and DDF does not (ibid., ibid.) . The data demonstrated that the diterpene augmentation of VBL uptake occurred independently of at least the protein kinase A pathway since DDF was the most potent modulator. This was supported by the lack of direct effect of dibutyryl cAMP on [3H]-VBL uptake. These data lend support to the cAMP-independent mechanism initially postulated by Wadler & Wiernik (1988) , but discount a direct role for a cAMP-dependent mechanism that may modulate PGP efflux activity at the level of the transporter itself. It therefore appears that the PKA pathway may play a prominent role in regulating the expression (Abraham et al., 1990) but not the direct activity of PGP.
Comparison offorskolin and DDF as modulators DDF was more potent than forskolin in enhancing uptake and was selectively active in KB-GRCl cells. The greater increase, 13.6-fold vs 1.4-fold in KB-3-1 cells, suggested that DDF interacted directly with PGP to inhibit efflux activity. The selective inhibition of efflux in KB-GRCI cells confirmed this. The same rank order for relative lipophilicity and ability to enhance VBL uptake was in good agreement with the ability of these agents to inhibit photolabelling of PGP (Morris et al., 1991) .
The hypothesis that VBL is a better substrate for PGP than doxorubicin in KB-GRCl cells is substantiated by the fact that KB-GRC1 cells are 7-fold more resistant to VBL than doxorubicin (Choi et al., 1988) . Furthermore, while VBL may not universally be a superior substrate of PGP compared to doxorubicin, VBL has been reported to inhibit the labelling of PGP by azidopine to a greater extent than doxorubicin in some MDR cell lines (Greenberger et al., 1990) . Thus, our results support previously published reports.
Modulation of influx and uptake An ability of PGP to efflux drug during the initial seconds of exposure has been established in KB-GRCI (Shalinsky et al., 1993) and other MDR tumour cells (Cano-Gauci et al., 1990) . Initial VBL influx (< 120 s) in KB-GRCI cells is energy-dependent and immediately potentiated by dipyridamole and verapamil (Shalinsky et al., 1993) , indicating the presence of PGP's rapid efflux activity. Furthermore, DDF has been shown to inhibit PGP-associated chloride channel activity within 30 s of exposure (Valverde et al., 1992) , substantiating that diterpene modulators can rapidly alter PGP function.
These diterpenes also produced increases in the rate constant for influx in KB-3-1 cells which would not be associated with PGP, but for which non-specific mechanisms have been largely excluded. It is possible that intracellular processes unrelated to membrane permeability were affected. Thus, these data implicated PGP-independent mechanisms which remain unknown.
However, the enhanced influx in KB- (Shalinsky et al., 1993) . Similarly, phenoxazine modulators have large effects on uptake but only < 30% effects on inhibiting initial efflux (Thimmaiah et al., 1990) . These data suggest that some factor may hinder the ability of the efflux blocker to exert its effect when the membrane or cytoplasm is saturated with the blocker, but the basis for this observation is unclear. Thus, the small effects on efflux observed in this study were consistent with other reports. It may therefore not be surprising that forskolin failed to significantly inhibit initial influx in lieu of its smaller ability to enhance uptake vs DDF, and due to the fact that forskolin is a poorer antagonist of the photolabelling of PGP relative to DDF (Morris et al., 1991) .
DDF and forskolin inhibited terminal efflux more prominently in cells irrespective of expression of mdrl, yet there was no evidence for a change in the tightly-bound fraction of VBL. Every MDR modulator we have studied produces a similar pattern (Shalinsky et al., 1993;  unpublished data), and it would be of great interest to elucidate the mechanism(s). The mechanism(s) responsible for this effect remains to be determined.
Selective modulation of cytotoxicity The ability of forskolin and DDF to enhance the uptake of VBL translated into a measurable increase in cytotoxicity selectively in the KB-GRCI cell line. The enhanced cytotoxicity mirrored well the ability of forskolin and DDF to augment VBL uptake and to inhibit photolabelling of PGP (Morris et al., 1991) . Median effect analysis demonstrated a highly synergistic interaction between VBL and DDF when cytotoxic concentrations of DDF were used. Similar testing was not done in KB-3-1 cells since in the absence of an effect on C., synergy was unlikely, and only additive effects have been observed between MDR modulators and VBL in previous studies in KB-3-1 cells (Shalinsky et al., 1990) . Forskolin may have been expected to produce less synergy with VBL than DDF, but prohibitive amounts of forskolin would have been required and thus these experiments were not done. Thus, DDF produced a large increase in sensitivity to VBL, and the synergistic nature was encouraging with regard to potential clinical utility. (Shalinsky et al., 1990a 
